Caption Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$955K 1955
2025
Q4
$955K Hold
100,000
0.01% 1069
2025
Q3
$976K Hold
100,000
0.01% 1113
2025
Q2
$607K Buy
+100,000
New +$751K 0.01% 1065
2024
Q1
Sell
-138,100
Closed -$5.02M 1595
2023
Q4
$5.02M Buy
+138,100
New +$5.32M 0.07% 337
2023
Q3
Sell
-14,900
Closed -$1.02M 1488
2023
Q2
$1.02M Buy
+14,900
New +$961K 0.02% 660
2022
Q4
Sell
-125,000
Closed -$7.58M 1631
2022
Q3
$7.58M Buy
+125,000
New +$3.95M 0.1% 230

Other funds holding PRTA

Caption Management's PRTA Position: Q1 2026 in Review

Caption Management sold out of Prothena Corp (PRTA) in Q1 2026, closing a stake of 61,009 shares — an estimated $583K sold.

Caption Management first reported a position in PRTA in Q1 2021 and held it in 6 quarters. The position peaked at $1.67M in Q4 2023. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Caption Management reported no remaining Prothena Corp position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 61,009 Prothena Corp shares in Q1 2026, an estimated $583K.
  • Caption Management first reported a position in Prothena Corp in Q1 2021 and held it in 6 quarters.
  • Caption Management's Prothena Corp position peaked at $1.67M in Q4 2023.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.